Centre National De La Recherche Scientifique`s Profile
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Centre National De La Recherche Scientifique look like?
Total Applications: | 3585 |
Granted Patents: | 2190 |
Grant Index | 72.37 % |
Abandoned/Rejected Applications: | 836 (27.63%) |
In-Process Applications: | 556 |
Average Grant Time: | 2.95 Years |
Average Office Actions: | 1.65 |
Which Technology Area Centre National De La Recherche Scientifique is filing most patents in? (Last 10 years)
Art Unit | Definition | Total Applications |
Opap | Parked GAU | 215 |
1648 | Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology | 76 |
1626 | Organic Chemistry | 70 |
1623 | Organic Chemistry | 62 |
1625 | Organic Chemistry | 62 |
How many patents are Centre National De La Recherche Scientifique filing every year?
Year | Total Applications |
2022 | 2* |
2021 | 162* |
2020 | 225 |
2019 | 278 |
2018 | 258 |
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Centre National De La Recherche Scientifique in USPTO?
Abstract:
None
Publication date: –
Applicant: Centre National De La Recherche Scientifique
Inventors: Anas Barr
Publication number: –
Abstract:
None
Publication date: –
Applicant: Centre National De La Recherche Scientifique
Inventors: Andreas Bikfalvi
Publication number: –
Abstract:
None
Publication date: –
Applicant: Centre National De La Recherche Scientifique
Inventors: Brown Richard
How are Centre National De La Recherche Scientifique’s applications performing in USPTO?
Application Number | Title | Status | Art Unit | Examiner |
17599785 | Imidazoline Derivatives As Cxcr4 Modulators | – | – | – |
17434225 | New Biomarkers And Biotargets In Renal Cell Carcinoma | – | – | – |
17430876 | 3,6-Disubstituted-2-Pyridinaldoxime Scaffolds | Docketed New Case – Ready for Examination | OPAP | Central, Docket |
17430961 | Optical Metasurfaces, And Associated Manufacturing Methods And Systems | – | – | – |